DEXTROAMPHETAMINE SULFATE

Pre-Launch

dextroamphetamine sulfate

ANDAORALTABLET

Lifecycle

Pre-Launch

Data completeness

3/8 — Basic

DEXTROAMPHETAMINE SULFATE (dextroamphetamine sulfate) by R-Pharm US is non-catecholamine sympathomimetic amines with cns stimulant activity. Approved for attention deficit hyperactivity disorder (adhd) in patients 13 years, older [see clinical studies ()], older and 1 more indications.

Drug data last refreshed 1mo ago

$0.0BPart D

Mechanism of Action

non-catecholamine sympathomimetic amines with CNS stimulant activity. The exact mode of therapeutic action in ADHD is not known.

Indications (3)

Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years older insomnia

Worked on DEXTROAMPHETAMINE SULFATE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.